Annual SG&A
$408.93M$31.31M-7.11%
Summary
- Current Value
- As of today, CLOV annual SG&A is $408.93M, down -7.11% on
- Historical Performance
- CLOV annual SG&A is down -8.26% over the past 3 years, and up +118.30% over the past 5 years
- All-Time High Comparison
- CLOV annual SG&A is currently -15.23% below its historical high of $482.40M set on
- 3-Year Low Comparison
- CLOV annual SG&A is at its 3-year low
- Sector Comparison
- CLOV annual SG&A is higher than 93.58% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $408.93M | -7.1% | -8.3% | +118.3% | +118.3% | |
| Quarterly SG&A | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| TTM SG&A | -$8.86B | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $2.54 | -29.4% | +151.5% | -84.1% | – | |
| Annual Operating Expenses | $410.27M | -5.8% | -26.4% | +109.6% | +109.6% | |
| Annual Operating Profit | -$45.46M | +74.7% | +92.9% | +75.2% | +75.2% | |
| Annual D&A | $1.33M | -47.0% | +6.8% | +141.6% | +141.6% | |
| Annual Revenue | $1.37B | +9.2% | -10.9% | +100.0% | +100.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $482.40M | N/A | -15.2% |
| 5Y | $482.40M | -15.2% | |
| All | $482.40M | -15.2% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $408.93M | at low | |
| 5Y | $192.09M | N/A | +112.9% |
| All | $187.33M | +118.3% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $408.93M | -7.1% | |
| $440.25M | -8.7% | |
| $482.40M | +8.2% |
| Year | Value | Change |
|---|---|---|
| $445.75M | +132.1% | |
| $192.09M | +2.5% | |
| $187.33M | - |
FAQ
What is the current annual SG&A of CLOV?
As of today, CLOV annual SG&A is $408.93M
What is 1-year change in CLOV annual SG&A?
CLOV annual SG&A is down -7.11% year-over-year
What is 3-year change in CLOV annual SG&A?
CLOV annual SG&A is down -8.26% over the past 3 years
How far is CLOV annual SG&A from its all-time high?
CLOV annual SG&A is currently -15.23% below its historical high of $482.40M set on December 31, 2022
How does CLOV annual SG&A rank versus sector peers?
CLOV annual SG&A is higher than 93.58% of companies in Healthcare sector
When is CLOV next annual earnings release?
The next annual earnings release for CLOV is on
Quarterly SG&A
$0.00$0.000.00%
Summary
- Current Value
- As of today, CLOV quarterly SG&A is $0.00, unchanged on
- Historical Performance
- CLOV quarterly SG&A has remained unchanged year-over-year, and unchanged over the past 3 years
- All-Time High Comparison
- CLOV quarterly SG&A vs all-time high is unknown
- 3-Year Low Comparison
- CLOV quarterly SG&A vs 3-year low value is unknown
- Sector Comparison
- CLOV quarterly SG&A is higher than 45.54% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual SG&A | $408.93M | – | -7.1% | -8.3% | +118.3% | |
| TTM SG&A | -$8.86B | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $2.54 | -5.9% | -29.4% | +151.5% | -84.1% | |
| Quarterly Operating Expenses | $41.90M | +296.1% | +349.4% | -44.2% | +258.5% | |
| Quarterly Operating Profit | -$41.90M | -296.1% | -349.4% | +44.2% | -258.5% | |
| Quarterly D&A | $406.00K | +3.0% | +19.8% | -34.1% | +194.2% | |
| Quarterly Revenue | $496.65M | +4.0% | +50.0% | -42.0% | +128.7% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of CLOV?
As of today, CLOV quarterly SG&A is $0.00
What is CLOV quarterly SG&A most recent change?
CLOV quarterly SG&A remained unchanged on September 30, 2025
What is 1-year change in CLOV quarterly SG&A?
CLOV quarterly SG&A has remained unchanged year-over-year
How far is CLOV quarterly SG&A from its all-time high?
CLOV quarterly SG&A vs all-time high is unknown
How does CLOV quarterly SG&A rank versus sector peers?
CLOV quarterly SG&A is higher than 45.54% of companies in Healthcare sector
When is CLOV next earnings release?
The next earnings release for CLOV is on
TTM SG&A
-$8.86B$58.32M-0.66%
Summary
- Current Value
- As of today, CLOV TTM SG&A is -$8.86B, down -0.66% on
- Historical Performance
- CLOV TTM SG&A is down -100.00% year-over-year, and down -100.00% over the past 3 years
- All-Time High Comparison
- CLOV TTM SG&A is currently -50344030.68% below its historical high of -$17.60K set on an earlier date
- 3-Year Low Comparison
- CLOV TTM SG&A is at its 3-year low
- Sector Comparison
- CLOV TTM SG&A is higher than 3.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$8.86B | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual SG&A | $408.93M | – | -7.1% | -8.3% | +118.3% | |
| Quarterly SG&A | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Price | $2.54 | -5.9% | -29.4% | +151.5% | -84.1% | |
| TTM Operating Profit | -$75.23M | -76.4% | -0.9% | +82.9% | -346.9% | |
| TTM D&A | $1.61M | +4.3% | -3.1% | -44.0% | +289.8% | |
| TTM Revenue | $1.77B | +10.3% | +32.2% | -41.3% | +215.4% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$8.73B | N/A | -1.4% |
| 3Y | -$7.38B | N/A | -20.0% |
| 5Y | -$1.03B | N/A | -759.0% |
| All | -$17.60K | N/A | >-9999.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$8.86B | N/A | at low |
| 3Y | -$8.86B | N/A | at low |
| 5Y | -$8.86B | N/A | at low |
| All | -$8.86B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of CLOV?
As of today, CLOV TTM SG&A is -$8.86B
What is CLOV TTM SG&A most recent change?
CLOV TTM SG&A was down -0.66% on September 30, 2025
What is 1-year change in CLOV TTM SG&A?
CLOV TTM SG&A is down -100.00% year-over-year
How does CLOV TTM SG&A rank versus sector peers?
CLOV TTM SG&A is higher than 3.74% of companies in Healthcare sector
When is CLOV next earnings release?
The next earnings release for CLOV is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- CLOV Official Website www.cloverhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1801170/000180117025000269/0001801170-25-000269-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1801170/000180117025000052/0001801170-25-000052-index.htm
- CLOV Profile on Yahoo Finance finance.yahoo.com/quote/CLOV
- CLOV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clov